Mem Inst Oswaldo Cruz, Rio de Janeiro, 105(8) December 2010
Assessing key safety concerns of a Wolbachia-based strategy to control dengue transmission by Aedes mosquitoes
ISchool of Biological Sciences, The University of Queensland, Brisbane QLD, St. Lucia, 4072 Australia
IIInstituto de Pesquisas René Rachou-Fiocruz, Belo Horizonte, MG, Brasil
IIISchool of Public Health, James Cook University, Cairns, Australia
Mosquito-borne diseases such as dengue fever, chikungunya or malaria affect millions of people each year and control solutions are urgently needed. An international research program is currently being developed that relies on the introduction of the bacterial endosymbiont Wolbachia pipientis into Aedes aegypti to control dengue transmission. In order to prepare for open-field testing releases of Wolbachia-infected mosquitoes, an intensive social research and community engagement program was undertaken in Cairns, Northern Australia. The most common concern expressed by the diverse range of community members and stakeholders surveyed was the necessity of assuring the safety of the proposed approach for humans, animals and the environment. To address these concerns a series of safety experiments were undertaken. We report in this paper on the experimental data obtained, discuss the limitations of experimental risk assessment and focus on the necessity of including community concerns in scientific research.
Biological control of agricultural, livestock and human pests has been undertaken successfully for centuries. For example, the biological control of citrus insect pests by ants has been described from as early as the 4th century AD in China (Hsi Han, cited in Wackers & van Rijn 2005). Biological control can be defined as the release into the environment of a biological agent to control a given pest through mechanisms such as predation, parasitism, herbivory or disease. In recent decades, more than 100 pest species have been targeted by the release of multiple biological control agents into the Australian environment. Iconic success include the release of myxoma virus to control rabbit populations (Saunders et al. 2010), the release of Cactoblastis moths to control prickley pear (Opuntia spp) (Dodd 1940), the introduction of dung beetles to manage cattle dung and the bush flies that breed in it (Edwards & Pavri 2007) and the control of floating Salvinia weed (Room et al. 1981) using the beetle Cyrtobagous singularis.
Dengue fever is a viral disease estimated to affect 50-100 million people annually and is primarily spread by the domestic mosquito Aedes aegypti (L.) (WHO 2009). The proposed approach aims to use the bacterium Wolbachia as a biological control agent to prevent the transmission of viruses such as dengue. Wolbachia are intracellular endosymbiotic bacteria naturally present in a large number of insects and other arthropod species (Werren et al. 2008). Some Wolbachia strains are also described as symbionts of filarial nematodes that infect humans and cause diseases such as river blindness and elephantiasis (Bandi et al. 1998). However, there is currently some controversy as to whether the Wolbachia that infect filarial nematodes should be classified as a separate species as their biology is quite distinct to the Wolbachia that infect insects (Pfarr et al. 2007). Wolbachia are able to actively spread into insect populations by manipulating insect reproduction (Werren et al. 2008). They are vertically transmitted across generations (via eggs) and confer reproductive advantages to infected females through a series of reproductive phenotypes that include cytoplasmic incompatibility, feminization, male killing or parthenogenesis (Werren et al. 2008). Wolbachia has long been considered as a potential biocontrol agent for insects and the pathogens they transmit, but has never been operationally deployed beyond pilot testing (Laven 1967, Beard et al. 1993, Sinkins & O'Neill 2000, Rasgon et al. 2003, Brownstein et al. 2003, Cook et al. 2007).
Wolbachia as a biological control agent against mosquito-borne diseases
Dengue viruses, like most pathogens transmitted by mosquitoes, need a significant period of development in the insect vector, termed the extrinsic incubation period (EIP), before they can be transmitted to a new host (Watts et al. 1987). Since the EIP is long relative to average mosquito lifespan, the majority of pathogen transmission is done by old mosquitoes. In 1997, a Wolbachia strain was discovered with virulent properties in its natural host, Drosophila melanogaster, halving adult lifespan (Min & Benzer 1997). It has been proposed that this strain, wMelPop, could be a biological agent to reduce lifespan of mosquitoes therefore reducing the proportion of infectious mosquitoes (Sinkins & O'Neill 2000, Brownstein et al. 2003, Cook et al. 2007). This strain has been successfully introduced into the dengue vector, Ae. aegypti, where it also reduces lifespan by up to 50%, while being maternally transmitted to 100% of the mosquito progeny (McMeniman et al. 2009).
A number of recent independent studies have shown that wMelPop and other Wolbachia strains can also confer resistance against a wide range of insect viruses as well as important human pathogens such as dengue and chickungunya viruses, Plasmodium gallinaceum, Plasmodium berghei or Brugia pahangi (Hedges et al. 2008, Teixeira et al. 2008, Kambris et al. 2009, 2010, Moreira et al. 2009a, Glaser & Meola 2010). This pathogen interference phenotype conferred by Wolbachia was observed in natural Drosophila hosts as well as in artificially introduced hosts such as Ae. aegypti (Moreira et al. 2009a, T Walker et al., unpublished observations). The discovery of pathogen interference effects opened a new approach where instead of reducing mosquito lifespan to reduce infectious mosquitoes in a population, the utilisation of Wolbachia as a biocontrol agent could rely on direct pathogen interference. Interestingly, even though Wolbachia is estimated to infect 65% of insect species, including multiple mosquito species (from the genus Culex, Aedes, Coquillettidia, Mansonia and Uranotaenia) the major vectors of dengue and malaria (Ae. aegypti and various anopheline mosquitoes, respectively) are not naturally infected by Wolbachia (Kittayapong et al. 2000, Ricci et al. 2002, Rasgon & Scott 2004, Hilgenboecker et al. 2008). The fact that many mosquito species are weak vectors could be due to the presence of Wolbachia symbionts, an interesting hypothesis that needs to be verified and could then provide evidence for a "natural" example of biological control by Wolbachia.
The proposed approach of using Wolbachia infections of Ae. aegypti as a biological control approach for dengue transmission is nearing open field testing in the course of an international research program associating collaborators from Australia, Vietnam, Thailand, USA and Brazil (www.mosquitoage.org/en/HOME.aspx). If these strains can spread in natural populations as they do in the laboratory, they could be an effective control solution against dengue transmission. A trial release of Wolbachia-infected Ae. aegypti is proposed for the 2010-2011 "wet season" in Cairns, Australia, prior to subsequent releases in Vietnam and Thailand.
Integrating community concerns in the scientific approach
Concomitantly with the scientific work on this approach, a social research and community engagement program was developed (2008-2009) and undertaken (2009-2010) in the city of Cairns - including the proposed release areas. Its aim was to develop an ethical, effective, culturally sensitive, stakeholder-directed framework for community engagement and authorisation that was sensitive to different socio-political settings (D McNaughton, unpublished observations).
Using a mixed methods approach, extensive social research and engagement were used to examine (i) how communities at the potential release sites wished to be engaged, (ii) what would constitute authorisation and (iii) acceptability and non-acceptability issues (McNaughton 2009). The results of this research were then used to develop a community engagement strategy and to develop mechanisms for addressing and responding to community questions and concerns (McNaughton et al. 2010, D McNaughton, unpublished observations).
"Community acceptability is critical to the future use and success of this program and public engagement, collaborative partnerships and community and regulatory authorisation have been recognised as an 'ethical requirement' of this type of project." (Newman et al. 2006, Lavery et al. 2008, D McNaughton, unpublished observations). Engaging communities early and identifying any concerns is critical to ethical engagement. It also provides a window for the research team to respond more effectively to community concerns, through new scientific experiments such as those described here as well as the creation of new communication materials, capacity building, education and ongoing engagement (D McNaughton, unpublished observations).
Social research into lay knowledge of dengue fever and acceptability of the Wolbachia method was undertaken in 2008-2009. Qualitative techniques including focus groups, in-depth interviews, questionnaires and participant observation were used initially to gauge the full range of views and then confirmed by data from quantitative measures such as telephone surveys which used representative population samples and randomised sampling techniques (McNaughton 2009, D McNaughton, unpublished observations).
The most common community concerns related to the safety of the approach and its capacity for transfer, namely: is the Wolbachia approach safe for people? Is it safe for animals and other organisms? Is it safe for the environment (D McNaughton, unpublished observations)?
Initially, these questions were answered by drawing on the large number of well-documented arguments in the extant literature, incorporating this information into communication materials and engagement activities. However, as these arguments rely on baseline knowledge of the biology of Wolbachia, dengue virus and Ae. aegypti it was thought they may not in themselves be enough to reassure the community who, in some instances, expected to be provided experimental data that would directly assess those risks. It was determined that answering these questions relied on experimental evaluation as well as on previous data, available observations and knowledge of the approach.
Can Wolbachia affect/be transferred to humans? Baseline data
A major concern the community repeatedly expressed was whether Wolbachia could be transferred to humans through the bite of infected mosquitoes (D McNaughton, unpublished observations). Wolbachia are specialized endosymbionts that infect insects as well as spiders, mites, terrestrial crustaceans (Breeuwer & Jacobs 1996, Bouchon et al. 1998, Taylor & Hoerauf 1999, Oh et al. 2000, Bandi et al. 2001, Rowley et al. 2004). Wolbachia have never been found in humans or other mammals, neither in birds, reptiles or fish. When Wolbachia were first discovered in the 1930's they were suspected of being potential human rickettsial pathogens and were tested accordingly (Hertig 1936). Preparations from Wolbachia infected ovaries were injected into chicken embryos but Wolbachia did not grow. They were also injected into baby mice both intraperitoneally and intracerebrally without symptoms or mortality that could be attributed to Wolbachia. The conclusion of these studies was that Wolbachia was a non-pathogenic symbiont of insects (Hertig 1936).
Humans have been exposed to Wolbachia for thousands of years. Wolbachia are extremely common in the environment naturally infecting a large range of insect species including pests of stored food products as well as insects that bite humans such as nuisance mosquitoes like Aedes albopictus and Culex quinquefasciatus. There is no evidence showing neither that residues of Wolbachia-infected insects in food products are harmful to humans nor are there any adverse effects reported from people being bitten by insects containing Wolbachia. In fact, as part of this project, human volunteers have been providing bloodmeals to Wolbachia-infected mosquitoes by using their own legs or arms, receiving thousands of bites without adverse consequences. This number is far higher than the number of potential bites people in the release areas would receive following the release of Wolbachia-infected mosquitoes.
The work reported in this manuscript used human volunteers for mosquito feeding as approved by the University of Queensland Human Ethical Committee - approval 2007001379. Written consent was obtained from each participant used for blood-feeding.
Can Wolbachia affect/be transferred to humans? Experimental assessment
Despite the evidence against negative effects of Wolbachia against humans, a number of experiments were undertaken to assess its potential transfer to humans and the potential development of an immune response specific to Wolbachia.
Transfer to humans? - One general concern is whether Wolbachia would be injected into the human body via the insect saliva during blood-feeding (D McNaughton, unpublished observations). In order to detect the presence of Wolbachia) polymerase chain reaction (PCR) analysis of the Ae. aegypti mosquito saliva has been performed (Moreira et al. 2009b). PCR amplification of the Wolbachia wsp gene and the mosquito apyrase gene showed that despite Wolbachia is present in salivary glands, it is absent in the saliva (Moreira et al. 2009b). Even when the transposable element IS5, present in at least 13 copies within the bacterial genome (Wu et al. 2004), was used as a very sensitive PCR target, no amplification was obtained. These negative PCR results are supported by the size of the intracellular Wolbachia (around 1-2 ?m in diameter) and the diameter of mosquito salivary ducts (less than 1 ?m), which indicate that even if Wolbachia was present in the secreted salivary fluid it would be unlikely to move freely through the salivary ducts (Moreira et al. 2009b). Nevertheless, Wolbachia antigens or residues could be injected into humans during biting which could then potentially induce an immune response.
Development of an immune response specific to Wolbachia? -We therefore investigated the antibody response specific to Wolbachia in the human volunteers that regularly feed mosquito colonies. Sera from human volunteers that blood-fed repeatedly the Wolbachia-infected mosquito lab colonies being exposed to many thousands of bites over a four-year time frame were collected [blood-feeder (BF), n = 17] for immunological analysis. Sera from humans who never blood-fed any mosquito lab colony were also collected as negative controls [non blood-feeder (NBF) n = 5]. Both Western blot and enzyme-linked immunosorbent assays (ELISA), classically used in combination for accurate diagnostics of human diseases such as human immunodeficiency virus (Sax et al. 2010), were performed for immunological detection of any possible human antibody specific to Wolbachia antigens.
For Western blots Wolbachia extracts were first loaded on SDS-PAGE gels and after blotting, membranes were incubated with either a rabbit anti-WSP (Wolbachia surface protein) antibody or with the different human sera from volunteers (Fig. 1). A single band with the right size for the Wolbachia WSP protein (26 kDa) (Braig et al. 1998) was detected only when the blot was incubated with an anti-WSP antibody (Fig. 1A). This same band was not detected when blots were incubated with the human sera from either BFs (which would recognize potential Wolbachia antigens) or non BFs. As a control, extracts from Wolbachia-uninfected mosquitoes were loaded on gels and the blots were incubated with human sera or with a mouse anti-mosquito saliva antibody [developed as shown by Drahota et al. (2009)] to detect whether volunteers were responding to mosquito bites (Fig. 1B). As previously shown (Orlandi-Pradines et al. 2007), most of the sera of exposed human subjects (BFs) recognized an Ae. aegypti protein of 45 kDa. Also, the majority of BFs responded to a smaller size band of around 37 kDa, which was previously named D7 (James et al. 1991) and has been shown to be recognized by exposed humans (Peng et al. 1998). These data show that human volunteers that have been exposed to many thousands of bites from Wolbachia-infected mosquitoes over prolonged periods of time have antibody responses to mosquito saliva but have not developed IgG antibodies specific to Wolbachia that could be detected by Western blot.
ELISA was also carried out on the individual sera to detect and measure the IgG antibodies specific to Wolbachia antigens to complement and verify the Western blots. Wolbachia were purified and homogenized from either Ae. aegypti cells or Drosophila flies using previously described protocol (McMeniman et al. 2008). The same purification protocol was applied to Wolbachia-uninfected Ae. aegypti cells and Drosophila to evaluate the IgG response specific to possible remaining insect antigens [background optical density (ODn)]. ELISA plates were coated with antigens and individual sera were added and incubated overnight. IgG detection was performed using a goat anti-human IgG antibody. Individual IgG levels specific to Wolbachia were expressed as difference of OD ("OD) values and calculated according to the formula "OD = ODw - ODn, where ODw represents the individual measure of OD for each purified Wolbachia samples.
Antigens coated on the ELISA plates were either Wolbachia extracts purified from Ae. aegypti cells (each well coated with purified Wolbachia from 3 x 104 cells) or Wolbachia extracts purified from Drosophila flies (each well coated with purified Wolbachia from 1 fly), along with their respective uninfected controls. For the two host backgrounds (either Ae. aegypti cells) (Fig. 2B) or Drosophila flies (Fig. 2C), no difference in the level of IgG specific to Wolbachia was detected between BFs and NBFs. As a control, Wolbachia-uninfected Ae. aegypti salivary gland extracts were coated on the ELISA plates (each well coated with 1/10th of a single salivary gland extract) and incubated with human sera to detect any IgG response specific to mosquitoes (Fig. 2A). BFs presented significantly higher IgG level specific to A. aegypti salivary gland extracts compared to NBFs (p = 0.0129), confirming the development of human antibody against mosquitoes as shown by the Western blot.
Both immunological investigations, Western blots and ELISA, show that humans repeatedly bitten by Wolbachia-infected Ae. aegypti develop antibodies against mosquitoes as already described for exposed humans, but do not develop IgG antibody against Wolbachia. All those results indicate that Wolbachia antigens are not injected into humans during the mosquito bloodmeal and therefore do not initiate an immune response in human host.
Can Wolbachia be transferred into the environment? Baseline data
Another major concern from the public is whether the release of Wolbachia infected mosquitoes would negatively affect the environment, that is whether Wolbachia could be transferred to other organisms or become established in the soil (D McNaughton, unpublished observations).
As for the previous question, a large piece of evidence indicates that this risk is negligible. Wolbachia is not infectious and is transmitted only vertically through the eggs from one generation to another (Werren et al. 2008). Wolbachia bacteria are obligate endosymbionts, that is, they can only live inside the cytoplasm of their host's cells and are not able to survive outside their host organism, and as such, they are not expected to persist in the environment outside the mosquitoes that carry them. Wolbachia will degrade together with mosquito bodies when they die and the residues will be indistinguishable from natural organic components and of no toxicological significance.
Transferring Wolbachia from flies into mosquitoes was a daunting task in the laboratory, which took several years. The recent success in obtaining transinfection of Ae. aegypti mosquitoes with the wMelPop strain (McMeniman et al. 2009) is believed to be due to the pre-adaptation of Wolbachia in Aedes tissue culture (McMeniman et al. 2008). This strain, initially isolated from D. melanogaster flies, was maintained for three years in tissue culture cells and only after this passaging scheme a stable infection in Ae. aegypti was successfully established by embryonic microinjection (McMeniman et al. 2009). Subsequent analysis of this strain after serial passage has revealed a number of genetic changes that occurred during the adaptation process (unpublished observations) and that were probably critical for the establishment of Wolbachia-infected mosquitoes. For some strains, the introduction of Wolbachia into a new host can be done without adaptation in cell line. Nevertheless, we believe that a successful introduction will still require hundreds to thousands of microinjections before obtaining a stable infection, at least in mosquito species (T Walker, unpublished observations). The difficulty of generating Wolbachia infections in new species indicates that the risk of horizontal transfer of Wolbachia to other lower flies is negligible.
Additional indirect evidence comes from the fact that Wolbachia-infected and uninfected species can coexist in the same habitat or predate on each other without acquiring the infection. In Australia, Ae. aegypti inhabits the same larval habitat as its close relative Aedes notoscriptus, which is naturally infected with Wolbachia (unpublished observations). However, extensive surveys of Ae. aegypti in Australia and around the world have determined that Ae. aegypti is not naturally infected with Wolbachia (Kittayapong et al. 2000, Ricci et al. 2002, Rasgon & Scott 2004). Despite the opportunity for Wolbachia to transfer naturally from Ae. notoscriptus to Ae. aegypti, which has been possible for the entire time that Ae. aegypti has been present in the Australian environment, that transfer has never happened.
An even larger natural experiment has been running in south east Asia where Ae. aegypti occurs in sympatry with Ae. albopictus. Again Ae. albopictus is naturally infected with two Wolbachia strains (Sinkins et al. 1995, Zhou et al. 1998, Dobson et al. 2001), often inhabits the same larval containers as Ae. aegypti and it is known that both species will ingest smaller instars of the other species. Again despite this close contact no natural transfer of Wolbachia has ever been reported from Ae. albopictus to Ae. aegypti. All these observations show that horizontal transmission does not occur easily or at a high frequency. These types of natural experiments do not provide evidence to support the case for frequent horizontal transfer.
This poses the interesting question of how does Wolbachia establish in insect hosts naturally if it is so hard to establish infections in the laboratory? This has been a central question for the Wolbachia research community for many years and despite considerable energy trying to answer this question by numerous research groups, mechanisms of natural transfer remain unknown. The only recorded examples of natural horizontal transfers have been between different parasitoids superinfecting the same insect host (Heath et al. 1999, Huigens et al. 2000, 2004). However this seems to be an unlikely explanation for a general mechanism. Furthermore parasitoids are not significant parasites of mosquitoes. The general consensus of the scientific community is that natural horizontal transfer events are extremely rare and the wide distribution of Wolbachia among insects is explained by the many millions of years that Wolbachia is believed to have been associated with insects, which in turn has allowed time for numerous rare events to accumulate.
Can Wolbachia be transferred into the environment? Experimental assessment
However, despite this body of evidence, and because of the concerns expressed by the community in the social research, a number of studies were conducted to evaluate if Wolbachia could be transferred from mosquitoes to other species. The possible horizontal transfer to mosquito predators and non-predator species or environments in the vicinity of the mosquitoes were evaluated.
Transfer to mosquito predators
In order to test the potential transfer of Wolbachia from infected mosquitoes into their natural predators, we designed predation experiments using two different spider species (Menemerus bivittatus and Pholcus phalangioides), commonly found in the Australian environment. Although some populations of these spiders contain Wolbachia infections (Rowley et al. 2004), the populations used in the experiments were not naturally infected, as determined by PCR using Wolbachia specific primers.
A first experiment was done using 80 jumping spiders (M. bivittatus, Salticidae) captured in Brisbane QLD, Australia. They were kept in individual containers and fed for four weeks with Wolbachia-infected mosquitoes (10 mosquitoes/spider/week) followed by two weeks of feeding with uninfected mosquitoes to clear their guts from possible remaining undigested infected mosquitoes. Spiders were then killed by freezing and stored at -20ºC until DNA extraction and PCR screening.
A second experiment was done on daddy long-legs spiders (P. phalangioides, Pholcidae). The experimental set up was similar to the previous one but it was extended for a longer period and a higher number of individuals were used. Twenty specimens were captured in Brisbane QLD and placed in five cages (30 x 30 x 30 cm). All cages contained males and at least one female in order to allow breeding. The spiders were fed with Wolbachia-infected mosquitoes during 16 weeks using up to 1,600 mosquitoes/cage/week as the population of spiders increased rapidly in all the cages. This feeding regime was followed by three weeks of feeding with uninfected mosquitoes to clear the spider guts from possible remaining undigested infected mosquitoes. The 412 spiders obtained after breeding and the 28 egg sacs present on females were then killed by freezing and stored at -20ºC prior to DNA extraction and PCR screening.
No jumping spiders were found positive for Wolbachia at the end of the first experiment. Similarly, after being fed as the sole food supply with thousands of Wolbachia-infected mosquitoes for weeks, and breeding in those conditions, only two daddy long-legs were positive for Wolbachia sequences. However, those two spiders were also positive for mosquito DNA, indicating that residual undigested infected mosquitoes were present within the spiders (Table I).
Overall, the experiments were done on more than 500 spiders and more than 900 eggs (through the analysis of 28 daddy long-legs egg sacs) from the two different species (jumping spiders and daddy long-legs). Those results show that the transmission of Wolbachia from mosquitoes to their spider predators is not a common event and was not observed in this experimental survey.
A last experiment was then performed to verify that Wolbachia did not disseminate in the environment surrounding large numbers of infected mosquitoes. Samples were collected in the Mosquito Research Facility (Cairns), a semi-field fully enclosed outdoor greenhouse style laboratory designed and constructed specifically for this project (www.mosquitoage.org/en/HOME.aspx.) in which thousands of Wolbachia-infected mosquitoes were bred for several months. The different samples collected were meant to represent a full variety of species or "environment" in which Wolbachia could have disseminated. Samples comprised soil samples, plant leaves and roots, earthworms and millipedes, all collected from inside the enclosure. DNA extraction from all the samples was then performed with appropriate protocols and the presence of Wolbachia in the samples was assessed by PCR targeting the specific IS5 Wolbachia genes.
The results of the screening done for the possible dissemination of Wolbachia to non-predator species and environmental samples show that no Wolbachia was detected in any of the samples collected in the semi-field cages where Wolbachia-infected mosquitoes were bred for months, neither in plants, soil, nor arthropods living in the cages (Table II).
All together, the results of these experiments show that there is no transmission of the bacteria to any of the environmental samples studied. These results are in fact not surprising and are consistent with the obligate intracellular status of Wolbachia and its maternal vertical transmission. One could say that the sample sizes of these experiments are such that very rare horizontal transmission events would not have been detected. However we can be confident from these experiments that horizontal transfer of Wolbachia to non-targets does not occur at high frequency.
Even if transfers did occur between individuals, the nature of Wolbachia invasions into insect populations is such that a critical threshold frequency of infection must be overcome before the Wolbachia infection can spread into a population. This threshold frequency relates directly to the fitness cost imposed by the Wolbachia infection on the host (Hoffmann & Turelli 1997, Turelli 2010) and in the case of the Wolbachia strains we have been working with, the threshold is estimated to fall between 0.2-0.45. That means that Wolbachia infection rate must exceed a local frequency of 20-45% before it can spread. The theory behind this prediction is explained in detail in the literature (Hoffmann & Turelli 1997, Turelli 2010).
Finally the consequence of any horizontal transmission events that might establish in foreign species needs to be considered. It is known that Wolbachia infections are quite common in the natural environment in a range of insect species, more than 60% of insects are estimated to be infected by Wolbachia (Hilgenboecker et al. 2008), including mosquitoes that commonly bite people such as Ae. notoscriptus, Ae. albopictus, Cx. quinquefasciatus and stored grain pests such as Tribolium (Wade & Chang 1995) Cadra and Ephestia (Ikeda et al. 2003), which leave residues in human food and even iconic species such as the protected Cairns Birdwing butterfly. Furthermore, within houses people host the fruit fly D. melanogaster, which is infected worldwide with the wMel strain of Wolbachia, one of the strains used in this project (Zhou et al. 1998). Considering the wide distribution of Wolbachia and no indications that it is impacting negatively on infected insect populations we would contend that the consequences of any harm arising from low probability transfer events would be negligible.
To implement or not to implement?
In conclusion, as it is our responsibility to insure that the "remedy will cause no harm", and as community concerns were centred upon safety and the possibility of Wolbachia transfer, a number of experiments were conducted to verify that the Wolbachia-based strategy to control mosquito-borne disease is safe for people, other organisms and the environment. The results presented in this paper show that no experimental evidence of any negative impact of Wolbachia-infected mosquitoes was obtained.
Assessing experimentally the potential consequences that could happen over a long-term period and large geographic scale could be a daunting task. Many questions related to long-term consequences can only be assessed once the release is done. Questions such as the evolution of the virus in response to the presence of Wolbachia, or the persistence of the virus blocking phenotype after generations in natural population are examples of key concerns for the scientific project and for the community but indeed require a priori the release to be answered.
To all human volunteers who donated their blood to be used in our experiments and to Robert Raven (Queensland Museum), for helpful advices on spider rearing.
Bandi C, Anderson TJC, Genchi C, Blaxter ML 1998. Phylogeny of Wolbachia in filarial nematodes. Proc R Soc Lond B Biol Sci 265: 2407-2413.
Bandi C, Trees AJ, Brattig NW 2001. Wolbachia in filarial nematodes: evolutionary aspects and implications for the pathogenesis and treatment of filarial diseases. Vet Parasitol 98: 215-238.
Beard CB, O'Neill SL, Tesh RB, Richards FF, Aksoy S 1993. Modification of arthropod vector competence via symbiotic bacteria. Parasitol Today 9: 179-183.
Bouchon D, Rigaud T, Juchault P 1998. Evidence for widespread Wolbachia infection in isopod crustaceans: molecular identification and host feminization. Proc R Soc Lond B Biol Sci 265: 1081-1090.
Braig HR, Zhou W, Dobson SL, O'Neill SL 1998. Cloning and characterization of a gene encoding the major surface protein of the bacterial endosymbiont Wolbachia pipientis. J Bacteriol 180: 2373-2378.
Breeuwer JA, Jacobs G 1996. Wolbachia: intracellular manipulators of mite reproduction. Exp Appl Acarol 20: 421-434.
Brownstein JS, Hett E, O'Neill SL 2003. The potential of virulent Wolbachia to modulate disease transmission by insects. J Invertebr Pathol 84: 24-29.
Cook PE, McMeniman CJ, O'Neill SL 2007. Modifying insect population age structure to control vector-borne disease. In S Aksoy, Transgenesis and the management of vector-borne disease, Landes Biosciences, Austin, 1-15.
Dobson SL, Marsland EJ, Rattanadechakul W 2001. Wolbachia-induced cytoplasmic incompatibility in single- and superinfected Aedes albopictus (Diptera: Culicidae). J Med Entomol 38: 382-387.
Dodd AP 1940. The biological campaign against prickly pear, Commonwealth Prickly Pear Board Bulletin, Brisbane, 177 pp.
Drahota J, Lipoldova M, Volf P, Rohousova I 2009. Specificity of anti-saliva immune response in mice repeatedly bitten by Phlebotomus sergenti. Parasite Immunol 31: 766-770.
Edwards PB, Pavri C 2007. Pastures-Dung beetles. In PT Bailey, Pests of field crops and pastures: identification and control, CSIRO Publishing, Collingwood, 471-484.
Glaser RL, Meola MA 2010. The native Wolbachia endosymbionts of Drosophila melanogaster and Culex quinquefasciatus increase host resistance to West Nile virus infection. PLoS One 5: e11977.
Heath BD, Butcher RD, Whitfield WG, Hubbard SF 1999. Horizontal transfer of Wolbachia between phylogenetically distant insect species by a naturally occurring mechanism. Curr Biol 9: 313-316.
Hedges LM, Brownlie JC, O'Neill SL, Johnson KN 2008. Wolbachia and virus protection in insects. Science 322: 702.
Hertig M 1936. The Rickettsia, Wolbachia pipientis (gen. et sp. n.) and associated inclusions of the mosquito, Culex pipiens. Parasitology 28: 453-486.
Hilgenboecker K, Hammerstein P, Schlattmann P, Telschow A, Werren JH 2008. How many species are infected with Wolbachia? - a statistical analysis of current data. FEMS Microbiol Lett 281: 215-220.
Hoffmann A, Turelli M 1997. Cytoplasmic incompatibility in insects. In SL O'Neill, A Hoffmann, JH Werren, Influential passengers. Inherited microorganisms and arthropod reproduction, Oxford University Press, Oxford, p. 42-80.
Huigens ME, de Almeida RP, Boons PA, Luck RF, Stouthamer R 2004. Natural interspecific and intraspecific horizontal transfer of parthenogenesis-inducing Wolbachia in Trichogramma wasps. Proc Biol Sci 271: 509-515.
Huigens ME, Luck RF, Klaassen RH, Maas MF, Timmermans MJ, Stouthamer R 2000. Infectious parthenogenesis. Nature 405: 178-179.
Ikeda T, Ishikawa H, Sasaki T 2003. Regulation of Wolbachia density in the Mediterranean flour moth, Ephestia kuehniella, and the almond moth, Cadra cautella. Zoolog Sci 20: 153-157.
James AA, Blackmer K, Marinotti O, Ghosn CR, Racioppi JV 1991. Isolation and characterization of the gene expressing the major salivary gland protein of the female mosquito, Aedes aegypti. Mol Biochem Parasitol 44: 245-253.
Kambris Z, Blagborough A, Pinto S, Blagrove M, Godfray H, Sinden R, Sinkins S, Vernick K 2010. Wolbachia stimulates immune gene expression and inhibits Plasmodium development in Anopheles gambiae. PLoS Pathog 6: 215-220.
Kambris Z, Cook PE, Phuc HK, Sinkins SP 2009. Immune activation by life-shortening Wolbachia and reduced filarial competence in mosquitoes. Science 326: 134-136.
Kittayapong P, Baisley KJ, Baimai V, O'Neill SL 2000. Distribution and diversity of Wolbachia infections in southeast Asian mosquitoes (Diptera: Culicidea). J Med Entomol 37: 340-345.
Laven H 1967. Eradication of Culex pipiens fatigans through cytoplasmic incompatibility. Nature 216: 383-384.
Lavery JV, Harrington LC, Scott TW 2008. Ethical, social and cultural considerations for site selection for research with genetically modified mosquitoes. Am J Trop Med Hyg 79: 312-318.
McMeniman CJ, Lane AM, Fong AW, Voronin DA, Iturbe-Ormaetxe I, Yamada R, McGraw EA, O'Neill SL 2008. Host adaptation of a Wolbachia strain after long-term serial passage in mosquito cell lines. Appl Environ Microbiol 74: 6963-6969.
McMeniman CJ, Lane RV, Cass BN, Fong AW, Sidhu M, Wang YF, O'Neill SL 2009. Stable introduction of a life-shortening Wolbachia infection into the mosquito Aedes aegypti. Science 323: 141-144.
McNaughton D 2009. The importance of social research for public engagement in bio-control releases: the case of the Eliminate Dengue Project. In Progress and prospects for the use of genetically modified mosquitoes to inhibit disease transmission, WHO, Geneva, 48-49.
McNaughton D, Clough A, Johnson P, Ritchie S, O'Neill S 2010. Beyond the "back yard": Lay knowledge about Aedes aegypti in northern Australia and its implications for policy and practice. Acta Trop 116: 74-80.
Min KT, Benzer S 1997. Wolbachia, normally a symbiont of Drosophila, can be virulent, causing degeneration and early death. Proc Natl Acad Sci USA 94: 10792-10796.
Moreira LA, Iturbe-Ormaetxe I, Jeffery JA, Lu G, Pyke AT, Hedges LM, Rocha BC, Hall-Mendelin S, Day A, Riegler M, Hugo LE, Johnson KN, Kay BH, McGraw EA, van den Hurk AF, Ryan PA, O'Neill SL 2009a. A Wolbachia symbiont in Aedes aegypti limits infection with dengue, Chikungunya, and Plasmodium. Cell 139: 1268-1278.
Moreira LA, Saig E, Turley AP, Ribeiro JM, O'Neill SL, McGraw EA 2009b. Human probing behavior of Aedes aegypti when infected with a life-shortening strain of Wolbachia. PLoS Negl Trop Dis 3: e568.
Newman RD, Moran AC, Kayentao K, Benga-De E, Yameogo M, Gaye O, Faye O, Lo Y, Moreira PM, Doumbo O, Parise ME, Steketee RW 2006. Prevention of malaria during pregnancy in west Africa: policy change and the power of subregional action. Trop Med Int Health 11: 462-469.
Oh HW, Kim MG, Shin SW, Bae KS, Ahn YJ, Park HY 2000. Ultrastructural and molecular identification of a Wolbachia endosymbiont in a spider, Nephila clavata. Insect Mol Biol 9: 539-543.
Orlandi-Pradines E, Almeras L, Denis de Senneville L, Barbe S, Remoue F, Villard C, Cornelie S, Penhoat K, Pascual A, Bourgouin C, Fontenille D, Bonnet J, Corre-Catelin N, Reiter P, Pages F, Laffite D, Boulanger D, Simondon F, Pradines B, Fusai T, Rogier C 2007. Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa. Microbes Infect 9: 1454-1462.
Peng Z, Li H, Simons FER 1998. Immunoblot analysis of salivary allergens in 10 mosquito species with worldwide distribution and the human IgE responses to these allergens. J Allergy Clin Immunol 101: 498-505.
Pfarr K, Foster J, Slatko B, Hoerauf A, Eisen JA 2007. On the taxonomic status of the intracellular bacterium Wolbachia pipientis: should this species name include the intracellular bacteria of filarial nematodes? Int J Syst Evol Microbiol 57: 1677-1678.
Rasgon J, Scott TW 2004. An initial survey for Wolbachia (Rickettsiales: Rickettsiaceae) infections in selected California mosquitoes (Diptera: Culcidae). J Med Entomol 41: 255-257.
Rasgon JL, Styer LM, Scott TW 2003. Wolbachia-induced mortality as a mechanism to modulate pathogen transmission by vector arthropods. J Med Entomol 40: 125-132.
Ricci I, Cancrini G, Gabrielli S, D'Amelio S, Favia G 2002. Searching for Wolbachia (Rickettsiales: Rickettsiaceae) in mosquitoes (Diptera: Culicidae): large polymerase chain reaction survey and new identifications. J Med Entomol 39: 562-567.
Room PM, Harley KLS, Forno IW, Sands DPA 1981. Successful biological control of the floating weed salvinia. Nature 294: 78-80.
Rowley SM, Raven RJ, McGraw EA 2004. Wolbachia pipientis in Australian spiders. Curr Microbiol 49: 208-214.
Saunders G, Cooke B, McColl K, Shine R, Peacock T 2010. Modern approaches for the biological control of vertebrate pests: an Australian perspective. Biol Control 52: 288-295.
Sax PE, Cohen CJ, Kuritzkes DR 2010. HIV essentials, 3rd ed., Physicians' Press Jones and Barlett Publishers, Sudbury, 252 pp.
Sinkins SP, Braig HR, O'Neill SL 1995. Wolbachia pipientis: bacterial density and unidirectional cytoplasmic incompatibility between infected populations of Aedes albopictus. Exp Parasitol 81: 284-291.
Sinkins SP, O'Neill SL 2000. Wolbachia as a vehicle to modify insect populations. In AA James, Insect transgenesis: methods and applications, CRC Press, Boca Raton, p. 271-287.
Taylor MJ, Hoerauf A 1999. Wolbachia bacteria of filarial nematodes. Parasitol Today 15: 437-442.
Teixeira L, Ferreira A, Ashburner M 2008. The bacterial symbiont Wolbachia induces resistance to RNA viral infections in Drosophila melanogaster. PLoS Biol 6: 2753-2763.
Turelli M 2010. Cytoplasmic incompatibility in populations with overlapping generations. Evolution 64: 232-241.
Wackers FL, van Rijn PC 2005. Food for protection: an introduction. In FL Wackers, PCJ van Rijn, J Bruin, Plant-provided food for carnivorous insects: a protective mutualism and its applications, Cambridge University Press, New York, p. 1-14.
Wade MJ, Chang NW 1995. Increased male fertility in Tribolium confusum beetles after infection with the intracellular parasite Wolbachia. Nature 373: 72-74.
Watts DM, Burke DS, Harrison BA, Whitmire RE, Nisalak A 1987. Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg 36: 143-152.
Werren JH, Baldo L, Clark ME 2008. Wolbachia: master manipulators of invertebrate biology. Nat Rev Microbiol 6: 741-751.
WHO 2009. Dengue and dengue hemorragic fever. Available from: http://www.who.int/csr/disease/dengue/en/.
Wu M, Sun LV, Vamathevan J, Riegler M, Deboy R, Brownlie JC, McGraw EA, Martin W, Esser C, Ahmadinejad N, Wiegand C, Madupu R, Beanan MJ, Brinkac LM, Daugherty SC, Durkin AS, Kolonay JF, Nelson WC, Mohamoud Y, Lee P, Berry K, Young MB, Utterback T, Weidman J, Nierman WC, Paulsen IT, Nelson KE, Tettelin H, O'Neill SL, Eisen JA 2004. Phylogenomics of the reproductive parasite Wolbachia pipientis wMel: a streamlined genome overrun by mobile genetic elements. PLoS Biol 2: e69.
Zhou W, Rousset F, O'Neil S 1998. Phylogeny and PCR-based classification of Wolbachia strains using wsp gene sequences. Proc Biol Sci 265: 509-515.